JN Macri Technologies

JN Macri Technologies is a specialized biotechnology and diagnostic company focused on the development of advanced prenatal screening technologies and risk assessment algorithms. Founded by Dr. James N. Macri, a pioneer in maternal-fetal medicine, the company is best known for its contributions to biochemical marker analysis for detecting chromosomal abnormalities and neural tube defects. Its proprietary software and methodologies are widely utilized by clinical laboratories and healthcare providers globally to calculate patient-specific risks for conditions such as Down syndrome and Trisomy 18. The company's work has been instrumental in establishing the global standards for first and second-trimester prenatal screening. By integrating biochemical data with clinical parameters, JN Macri Technologies provides the foundational science for many of the world's leading prenatal diagnostic platforms.